Under construction – not a live service
Sign in
Taking people in AustraliaNo phase

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

Key facts

Where
Adelaide, Beechina, Bowen Hills, Brisbane, Cairns, Canberra, Hackney, Hobart, Melbourne, Perth, Sydney, Townsville, and Woodford, AustraliaSee the 13 sites

Where in Australia

  • South Australian Prison Health ServiceAdelaide, AustraliaContact: Tom TurnbullNot yet recruiting
  • Acacia PrisonBeechina, AustraliaContact: Tahlia KinnaneTaking people
  • Queensland Injectors Health Network LtdBowen Hills, AustraliaContact: David Silk, BScNo longer taking part
  • West Moreton Hospital and Health ServiceBrisbane, AustraliaContact: Chris WallisTaking people
  • Lotus Glen Correctional CentreCairns, AustraliaContact: Kerry WilliamsonTaking people
  • ACT Justice HealthCanberra, AustraliaContact: Alex MisevNot yet recruiting
  • Hepatitis South AustraliaHackney, AustraliaContact: Lisa CarterNot yet recruiting
  • Tasmanian Prison ServiceHobart, AustraliaContact: Deborah SiddellNot yet recruiting
  • St Vincent's Hospital MelbourneMelbourne, AustraliaContact: Alex ThompsonTaking people
  • WA Department of JusticePerth, AustraliaContact: Holly BeasleyNot yet recruiting
  • Justice Health and Forensic Mental Health NetworkSydney, AustraliaContact: Tracey BrownTaking people
  • Townsville Correctional CentreTownsville, AustraliaContact: John MoreyNot yet recruiting
  • Woodford Correctional CentreWoodford, AustraliaContact: Lyn CadmanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Kirby Institute
Trial code
NCT05713136
Record updated
28 September 2026
Original description
The goal of this observational study is to learn if offering a point-of-care screening test for exposure to the Hepatitis C virus, before providing a diagnostic test for Hepatitis C infection can increase testing, diagnosis and treatment in Adults. Participants will be recruited from settings that provide services to people with a risk factor for the acquisition of Hepatitis C viral infection. The main question it aims to answer is:Read full original descriptionShow less

The National Australian HCV Point-of-Care Testing Program: An Observational Cohort Study to Evaluate the Use of Finger-stick Point-of-care Hepatitis C Testing to Enhance Diagnosis and Treatment of HCV Infection - HCV Antibody Testing Minimal Dataset

The goal of this observational study is to learn if offering a point-of-care screening test for exposure to the Hepatitis C virus, before providing a diagnostic test for Hepatitis C infection can increase testing, diagnosis and treatment in Adults. Participants will be recruited from settings that provide services to people with a risk factor for the acquisition of Hepatitis C viral infection. The main question it aims to answer is:

What proportion of the participants that have been diagnosed with HCV infection have started treatment when their records are reviewed 12 weeks after diagnosis?

Participants will have one in-person visit where they will provide informed consent and receive a finger-prick rapid result test for Hepatitis C infection. Participants with no previous Hepatitis C infection will have a screening test to see if they have an immune reaction to Hepatitis C. Participants who know they have been infected with Hepatitis C in the past, and all participants with a positive screening test result will then be given a Hepatitis C diagnostic test at this visit.

No treatment is provided as a part of this study, participants who are diagnosed with Hepatitis C infection will be referred to testing locations standard of care for any additional clinical assessments and treatment initiation. A review of the participant's records will be made 12 weeks after their Hepatitis C result and their treatment data are gathered.

Inclusion: Provide informed consent; ≥ 18 years of age.

Exclusion: Is unable or unwilling to provide informed consent.

ClinicalTrials.gov NCT05713136